Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoji Taniguchi

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Circulation Reports|March 11, 2021
Association of Previous Hospitalization for Heart Failure With Increased Mortality in Patients Hospitalized for Acute Decompensated Heart FailureKanae Su, Takao Kato, Mamoru Toyofuku, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 28, 2021
Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary InterventionMasahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 18, 2023
Polypharmacy and Bleeding Outcomes After Percutaneous Coronary InterventionKo Yamamoto, Takeshi Morimoto, Masahiro Natsuaki, et al.
Circulation. Cardiovascular Interventions|May 24, 2012
Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2Tomohisa Tada, Masahiro Natsuaki, Takeshi Morimoto, et al.
BMJ Open|February 23, 2021
Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3Yasuaki Takeji, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 17, 2023
Dual Antiplatelet Therapy Duration After Multivessel Optimal Intravascular Ultrasound-Guided Percutaneous Coronary InterventionKo Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
Plos One|December 28, 2020
Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort studyTakao Kato, Hidenori Yaku, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 29, 2025
CORRIGENDUM: Dual Antiplatelet Therapy Duration After Multivessel Optimal Intravascular Ultrasound-Guided Percutaneous Coronary InterventionKo Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology|September 9, 2021
Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary InterventionKo Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.
ESC Heart Failure|May 16, 2024
Development of interpretable machine learning models to predict in-hospital prognosis of acute heart failure patientsMunekazu Tanaka, Hirohiko Kohjitani, Erika Yamamoto, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Circulation Reports|March 11, 2021
Association of Previous Hospitalization for Heart Failure With Increased Mortality in Patients Hospitalized for Acute Decompensated Heart FailureKanae Su, Takao Kato, Mamoru Toyofuku, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 28, 2021
Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary InterventionMasahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 18, 2023
Polypharmacy and Bleeding Outcomes After Percutaneous Coronary InterventionKo Yamamoto, Takeshi Morimoto, Masahiro Natsuaki, et al.
Circulation. Cardiovascular Interventions|May 24, 2012
Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2Tomohisa Tada, Masahiro Natsuaki, Takeshi Morimoto, et al.
BMJ Open|February 23, 2021
Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3Yasuaki Takeji, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 17, 2023
Dual Antiplatelet Therapy Duration After Multivessel Optimal Intravascular Ultrasound-Guided Percutaneous Coronary InterventionKo Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
Plos One|December 28, 2020
Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort studyTakao Kato, Hidenori Yaku, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 29, 2025
CORRIGENDUM: Dual Antiplatelet Therapy Duration After Multivessel Optimal Intravascular Ultrasound-Guided Percutaneous Coronary InterventionKo Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology|September 9, 2021
Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary InterventionKo Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.
ESC Heart Failure|May 16, 2024
Development of interpretable machine learning models to predict in-hospital prognosis of acute heart failure patientsMunekazu Tanaka, Hirohiko Kohjitani, Erika Yamamoto, et al.
Pageof 10